Výsledky vyhledávání

Akademický článek

Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma

Autor: Liping Lin, Xuan Wu, Yuanxue Jiang, Caijiu Deng, Xi Luo, Jianjun Han, Jiazhu Hu, Xiaolong Cao

Publikováno v: PeerJ, Vol 10, p e13402 (2022)

Neural precursor cell expressed developmentally down-regulated 4-like protein (NEDD4L), an E3 ubiquitin ligase, exerts an important role in diverse biological processes including development, tumorigenesis, and tumor progression. Although the role of

Externí odkaz: https://doaj.org/article/b151c486091f402a96312ecba1ace630

Zobrazit plný text záznamu

Immune checkpoint inhibitors’ combination therapy as first-line treatment in advanced esophageal squamous cell carcinoma: a meta-analysis

Autor: Dianhe, Li, Ling, Tang, Jiazhu, Hu, Xiaolong, Cao, Yan, He

Publikováno v: Journal of Cancer Research and Clinical Oncology. 149:933-939

The benefit of immune checkpoint inhibitors' (ICIs) combination therapy in patients with advanced esophageal squamous cell carcinoma (ESCC) remained unclear. We performed a meta-analysis to explore the efficacy and safety of ICIs' combination therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe4f9926f3f2bbc2d191d6f96ac9da4
https://doi.org/10.1007/s00432-022-04066-2

Zobrazit plný text záznamu

Akademický článek

Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib

Autor: Liping Lin, Fuxi Huang, Fang Chen, Yan He, Jiazhu Hu, Xiaolong Cao

Publikováno v: Journal of International Medical Research, Vol 46 (2018)

Pulmonary pleomorphic carcinoma (PPC) is rare, and the response of patients to conventional chemotherapy is very poor. Here we present a patient with anaplastic lymphoma kinase (ALK)-rearranged advanced PPC treated with crizotinib. Computed tomograph

Externí odkaz: https://doaj.org/article/a5bac0152d8c4202b631187cddac091d

Zobrazit plný text záznamu

The Cinque Ports and Great Yarmouth in dispute in 1316: Maritime violence, royal mediation and political language

Autor: Jiazhu Hu

Publikováno v: International Journal of Maritime History. 32:666-680

Before the Tudors, England had no standing navy, and relied heavily on its urban corporations for shipping and coastal defence. Despite their significant naval contribution to medieval England, eminent maritime communities such as the Cinque Ports we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bc3ccdab87eac0434a770968a61dc9
https://doi.org/10.1177/0843871420944650

Zobrazit plný text záznamu

Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming

Autor: Wangjun Liao, Dongping Chen, Kelin Lin, Bishan Liang, Yujing Tan, Yanxiao Liang, Jiazhu Hu, Shuyi Zhang, Qiong Huang, Qijing Wu, Jingyu Li, Wanming He, Xingbin Hu, Min Shi, Yang Zhao, Jin Wang, Hao Wang, Zhiqi Yao, Yajing Liu

Publikováno v: Theranostics

Omental metastasis occurs frequently in gastric cancer (GC) and is considered one of the major causes of gastric cancer-related mortality. Recent research indicated that omental adipocytes might mediate this metastatic predilection. Phosphatidylinosi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::176d18f3cdb89f933ad30c8b158cf482
https://doi.org/10.7150/thno.28219

Zobrazit plný text záznamu

Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Treated with Pemetrexed Continuation Maintenance

Autor: Xiaolong Cao, Jianjun Han, Fuxi Huang, Yan He, Guorong Zou, Liping Lin, Juanjuan Zhao, Jiazhu Hu

Publikováno v: Journal of Cancer. 9:2140-2146

Objectives: The aim of this study is to investigate the predictive value of smoking history on treatment outcomes of pemetrexed continuation maintenance therapy in advanced non-squamous NSCLC patients without EGFR mutations and ALK rearrangements. Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09148bd810da15d8d75a3756f4e1b92f
https://doi.org/10.7150/jca.24872

Zobrazit plný text záznamu

Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors

Autor: Fuxi Huang, Ning Kong, Jiazhu Hu, Liping Lin, Xiaolong Cao, Juanjuan Zhao, Jianjun Han, Yan He

Publikováno v: Oncotarget

// Liping Lin 1, 4, * , Juanjuan Zhao 2, * , Ning Kong 3, 4 , Yan He 1, 4 , Jiazhu Hu 1, 4 , Fuxi Huang 1, 4 , Jianjun Han 1, 4 and Xiaolong Cao 1, 4 1 Department of Oncology, Panyu Central Hospital, Guangzhou, 511400, China 2 School of Nursing, Sun

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00dd12d9937bf58bfa827d16ae9d836
https://doi.org/10.18632/oncotarget.18283

Zobrazit plný text záznamu

Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience

Autor: Xiaolong Cao, Fuxi Huang, Liping Lin, Juanjuan Zhao, Yan He, Jianjun Han, Jiazhu Hu

Publikováno v: OncoTargets and therapy

PURPOSE Both gefitinib and pemetrexed maintenance were effective therapies for advanced lung adenocarcinoma, but which is better is unclear. For patients with advanced lung adenocarcinoma, we have no idea whether we should choose gefitinib or pemetre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0979448f182d167b0a9f9365dc2f61bb
http://europepmc.org/articles/PMC5072510

Zobrazit plný text záznamu